{"doi":"10.1002/hon.3142","title":"Peripheral T‐cell lymphomas","abstract":"<jats:title>Abstract</jats:title><jats:p>The treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients? Do we require an autologous stem cell transplantation in all patients? Is there room for improvement in the setting of relapsed and refractory disease?</jats:p>","journal":"Hematological Oncology","year":2023,"id":600512,"datarank":0.38474240361923057,"base_score":2.5649493574615367,"endowment":2.5649493574615367,"self_citation_contribution":0.38474240361923057,"citation_network_contribution":0.0,"self_endowment_contribution":0.38474240361923057,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":12,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":488588,"name":"Pier Luigi Zinzani","orcid":"0000-0002-2112-2651","position":1,"is_corresponding":false},{"id":898413,"name":"Alessandro Broccoli","orcid":"0000-0001-5633-7313","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Peripheral T‐cell lymphomas","abstract":"<jats:title>Abstract</jats:title><jats:p>The treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients? Do we require an autologous stem cell transplantation in all patients? Is there room for improvement in the setting of relapsed and refractory disease?</jats:p>","is_dataset_classified":null,"base_score":2.5649493574615367,"endowment":2.5649493574615367,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"37294962","pmcid":null,"openalex_id":"https://openalex.org/W4379979996","authors":[],"funders":[],"total_grants":0,"fwci":2.1175,"citation_percentile":0.87012797,"influential_citations":0,"citation_trend":[{"year":2024,"count":5},{"year":2025,"count":5},{"year":2026,"count":2}],"oa_status":"bronze","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.3142","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.3142","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3142","host_type":"publisher"},{"url":"https://doi.org/10.1002/hon.3142","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/37294962","host_type":"repository"},{"url":"https://hdl.handle.net/11585/960692","host_type":"repository"}],"fields_of_study":["Lymphoma Diagnosis and Treatment","Cutaneous lymphoproliferative disorders research","T-cell and Retrovirus Studies","Humans","Lymphoma, T-Cell, Peripheral","Hematopoietic Stem Cell Transplantation","Transplantation, Autologous","Treatment Outcome","Prognosis","Immunoconjugates"],"mesh_terms":["Humans","Prognosis","Transplantation, Autologous","Lymphoma, T-Cell, Peripheral","Treatment Outcome","Hematopoietic Stem Cell Transplantation","Immunoconjugates"],"keywords":["Medicine","Peripheral","Lymphoma","Peripheral T-cell lymphoma","Disease","T cell","Presentation (obstetrics)","Refractory (planetary science)","Transplantation","T-cell lymphoma","Oncology","Internal medicine","Immunology","Immune system","Surgery","Biology","Azacitidine","Brentuximab Vedotin","Peripheral T-cell Lymphomas","Duvelisib","Linperlisib","Valemetostat","Golidocitinib"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T13:20:29.161375Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}